Asst. Prof. NAZİYE AK


Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı


WoS Research Areas: Clinical Medicine (Med), Clinical Medicine, Oncology

Scopus Research Areas: Oncology

Avesis Research Areas: Medicine, Internal Medicine Sciences, Internal Diseases, Oncology, Health Sciences

Names in Publications: Naziye A.K., Ak Naziye

Metrics

Publication

93

Publication (WoS)

67

Publication (Scopus)

66

Citation (WoS)

202

H-Index (WoS)

9

Citation (Scopus)

232

H-Index (Scopus)

9

Citation (Scholar)

26

H-Index (Scholar)

2

Citation (Sobiad)

1

H-Index (Sobiad)

1

Total Citation Count

203

Project

4

Thesis Advisory

3

Open Access

13
UN Sustainable Development Goals

Research Areas

Avesis Research Areas: Medicine, Internal Medicine Sciences, Internal Diseases, Oncology, Health Sciences
WoS Research Areas: Clinical Medicine (Med), Clinical Medicine, Oncology
Scopus Research Areas: Oncology

Research Areas Based on Academic Activities

Avesis Research Areas

    WoS Research Areas

      Scopus Research Areas

        Education

        2022 - Present

        2022 - Present

        Doctorate

        Istinye University, Lisansüstü Eğitim Enstitüsü, Moleküler Onkoloji (DR), Turkey

        2017 - 2020

        2017 - 2020

        Post Doctorate of Medicine

        Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey

        2012 - 2016

        2012 - 2016

        Expertise In Medicine

        Istanbul University, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Turkey

        2005 - 2011

        2005 - 2011

        Undergraduate

        Istanbul University, Cerrahpaşa Tıp Fakültesi, İngilizce Tıp, Turkey

        Dissertations

        2016

        2016

        Expertise In Medicine

        MEME KANSERİNDE NEOADJUVAN KEMOTERAPİ YANITINI PREDİKTE EDEN PATOLOJİK FAKTÖRLER Sustainable Development

        Istanbul University, Cerrahpaşa Tıp Fakultesi, İç Hastalıkları Anabilim Dalı

        2016

        2016

        Expertise In Medicine

        Meme kanserinde neoadjuvan kemoterapi yanıtını predikte eden patolojik faktörler

        İstanbul University-Cerrahpaşa, Cerrahpasa Faculty Of Medicine, Department Of Internal Medicine

        Foreign Languages

        B1 Intermediate

        B1 Intermediate

        English

        Certificates, Courses and Trainings

        2018

        2018

        PSİKOONKOLOJİ 2. DÜZEY KLİNİSYEN EĞİTİMİ

        Education Management and Planning

        PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ

        2017

        2017

        AİLE DANIŞMANLIĞI

        Education Management and Planning

        ULUDAĞ ÜNİVERSİTESİ-UZAKTAN EĞİTİM

        2017

        2017

        İMMUNOONKOLOJİ KURSU

        Health&Medicine

        TÜRK TIBBİ ONKOLOJİ DERNEĞİ

        2017

        2017

        PSİKOONKOLOJİ 1. DÜZEY KLİNİSYEN EĞİTİMİ

        Education Management and Planning

        PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ

        Academic Positions

        2024 - Present

        2024 - Present

        Assistant Professor

        Istanbul University, Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı

        2023 - 2024

        2023 - 2024

        Associate Professor

        Istanbul Bilim University

        2017 - 2020

        2017 - 2020

        Research Assistant

        Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

        2012 - 2016

        2012 - 2016

        Research Assistant

        İstanbul University-Cerrahpaşa, Cerrahpasa Faculty Of Medicine, Department Of Internal Medicine

        Articles

        All (69)
        SCI-E, SSCI, AHCI (56)
        SCI-E, SSCI, AHCI, ESCI (63)
        ESCI (7)
        Scopus (66)
        TRDizin (12)
        Other Publications (1)

        2021

        2021

        55.

        MINARECI Y., TOSUN Ö., Ak N., SÖZEN H., TOPUZ S., SALIHOGLU M. Y.

        Kocaeli Tıp Dergisi , vol.10, no.3, pp.217-224, 2021 (Peer-Reviewed Journal) Creative Commons License

        Papers Presented at Peer-Reviewed Scientific Conferences

        2026

        2026

        1. Serum miR-181-5p, miR-214-3p, and miR-223-3p expression in epithelial ovarian cancer.

        AK N., Baspinar S. N., KÜÇÜKGERGİN C., Minareci Y., Sozen H., TOPUZ S., et al.

        Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 29 May - 02 June 2026, vol.44, (Summary Text)

        2025

        2025

        2. PERCUTANEOUS CRYOABLATION FOR EARLY-STAGE BREAST CANCER: INITIAL EXPERIENCE AND SHORTTERM OUTCOMES

        Kızıldağ Yırgın İ., Çelik L., Cömert Bozkurt R. G., Kılıç B., Yılmaz C., İbiş K., et al.

        18. Ulusal Meme Hastalıkları Kongresi, İskele, Cyprus (Kktc), 27 - 30 November 2025, pp.96-99, (Summary Text)

        2023

        2023

        4. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS

        Minareci Y., Ak N., Sözen H., Tosun Ö., Küçükgergin C., Aydın A. F., et al.

        ESGO 2023 European Congress on Gynaecological Oncology, İstanbul, Turkey, 28 September - 01 October 2023, vol.33, pp.242, (Summary Text)

        2019

        2019

        7. Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study

        Karabulut S., Dogan I., Ak N., Afsar C. U., Karabulut M., Tastekin D.

        44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.305, (Summary Text) Sustainable Development

        2019

        2019

        8. Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study

        AK N.

        European Society for Medical Oncology Congress 2019, Barcelona, Spain, 27 September - 01 October 2019, pp.424-430, (Summary Text) Sustainable Development

        2019

        2019

        9. THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY

        AK N.

        World Conferrence of Lung Cancer 2019, Barcelona, Spain, 7 - 10 September 2019, pp.933-934, (Summary Text)

        2019

        2019

        10. OUTCOMES OF THYMOMA AND DETERMINANTS OF SURVIVAL: 16 YEARS EXPERIENCE OF A TERTIARY CANCER CENTER

        AK N.

        World Conferrence of Lung Cancer, Barcelona, Spain, 7 - 10 September 2019, pp.1095-1096, (Summary Text)

        2019

        2019

        11. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels

        Tuzer O. C., Sari M., Aktas E., Ak N., Buyukozturk S., Colakoglu B., et al.

        Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.737-738, (Summary Text)

        2019

        2019

        12. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels

        TÜZER C., SARI M., ÇETİN E., AK N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.

        European Academy of Allergy and Clinical Immunology (EAACI) 2019, 1 - 05 June 2019, pp.150, (Summary Text)

        2019

        2019

        13. Significance of adiposity in endometrial cancer prognosis.

        KIZILDAĞ YIRGIN İ., ENGİN G., ÇELİK E., TOPUZ S., AK N., SAİP P.

        Türk manyetik rezonans derneği.24.Uluslararası katılımlı yıllık bilimsel toplantısı. 2019, Ankara, Turkey, 25 - 27 April 2019, (Full Text) Sustainable Development

        2018

        2018

        14. Platin ile hızlı desensitizasyonun sitokin düzeylerine etkisi P -29

        Tüzer Ö. C., Sarı M., ÇETİN E., Ak N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.

        XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, pp.111, (Full Text)

        2013

        2013

        15. IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu

        BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E., AR M. C., et al.

        39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 - 26 October 2013, no.261, pp.277-278, (Full Text)

        2012

        2012

        16. IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu

        BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E., AR M. C., et al.

        38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, no.261, pp.277-278, (Full Text)

        Books

        2020

        2020

        1. Göğüs duvarı tümörlerinde kemoterapi

        AK N., Keskin S.

        in: Göğüs duvarı hastalıkları ve cerrahisi, Ali Cevat Kutluk, Soner Gürsoy, Editor, Türkiye Solunum Araştırmaları derneği, pp.209-2013, 2020

        2019

        2019

        2. Endometrium Kanserleri

        AK N.

        in: Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, CİHAN S, GEREDELİ Ç, DEMİR C., Editor, Tıbbi Yayınlar Merkezi, İstanbul, pp.113-122, 2019

        2019

        2019

        3. Systemic Treatment Drugs/Regimens and Dose Modifications

        AK N.

        in: Breast Disease, Aydiner A., Igci A., Soran A., Editor, Springer, Cham, Isviçre, pp.789-801, 2019

        2019

        2019

        4. Systemic Treatment Drugs/Regimens and Dose Modifications

        AK N., AYDINER A.

        in: Breast Disease, Adnan Aydiner, Abdullah Igci, Atilla Soran, Editor, Springer Cham, pp.789-801, 2019

        2019

        2019

        5. Timus hastalıklarında kemoterapi

        AK N., AYDINER A.

        in: Timus hastalıkları ve tedavisi, Dr. Koray Dural, Dr. Berker Özkan, Dr. Berkant Özpolat, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.180-185, 2019

        2018

        2018

        6. Systemic Treatment Drugs and Regimens

        AK N.

        in: Breast Cancer A Guide to Clinical Practice, Aydiner A, Igci A, Soran A., Editor, Springer International Publishing, Copyright Holder Springer Nature Switzerland Ag, pp.587-608, 2018 Sustainable Development

        2018

        2018

        7. Systemic Treatment Drugs and Regimens

        AK N., AYDINER A.

        in: Breast Cancer, Adnan Aydiner, Abdullah Igci, Atilla Soran, Editor, Springer Cham, pp.587-608, 2018

        Peer Reviews in Scientific Publications

        September 2019

        September 2019

        21st World Congress of Psycho-Oncology /Abstract Reviewer

        Other journals